RCT | Effect of Dimethyl Fumarate vs. Interferon Beta-1a in patients with pediatric-onset multiple sclerosis.
29 Sep, 2022 | 13:29h | UTCInvited Commentary: Considering the Future of Pediatric Multiple Sclerosis Trials After the CONNECT Open-Label Randomized Trial – JAMA Network Open
See also: Visual Abstract